InsiderSource

Coric Vlad

Director, Chief Executive Officer · SEC CIK 1704317
Insider at RPRX Royalty Pharma plc BHVN Biohaven Pharmaceutical Holding Co Ltd. MANE Veradermics, Inc RVNC Revance Therapeutics, Inc.

Buy track record

How this insider's open-market purchases have performed
23%
of buys now in profit
5 up · 17 down
Avg return since buy+1.3%
Median return−7.2%
Best trade+154.0%
Worst trade−76.3%
Buys scored22
Average return by holding period — separates good entry timing from riding one long winner
After 1 month +19.7% 77% won · 22 trades
After 3 months +37.6% 86% won · 22 trades
After 6 months +12.2% 70% won · 20 trades
After 12 months +72.8% 83% won · 18 trades
DateCompany90d trendBuy priceValue1M3M6M12MTo date
Feb 5, 2026 MANE $17 $1,000K +30.8% +208.9% — — +154.0%
Feb 5, 2026 MANE $17 $1,000K +30.8% +208.9% — — +154.0%
Nov 13, 2025 BHVN $8 $2.5M +39.6% +40.6% +11.8% — +40.7%
Nov 13, 2025 BHVN $8 $2.5M +39.6% +40.6% +11.8% — +40.7%
Oct 2, 2024 BHVN $48 $1,000K +4.3% −22.3% −50.7% −67.7% −76.3%
Apr 22, 2024 BHVN $41 $5M −0.9% −4.9% +37.4% −44.8% −70.3%
Oct 5, 2023 BHVN $22 $7.5M +19.5% +76.4% +117.5% +118.4% −52.9%
Oct 5, 2023 BHVN $22 $2.5M +19.5% +76.4% +117.5% +118.4% −52.9%
Oct 31, 2022 BHVN $16 $412K −0.2% +15.2% −18.0% +60.0% −31.4%
Oct 28, 2022 BHVN $15 $623.4K −6.0% +21.2% −14.7% +80.2% −25.8%
Oct 28, 2022 BHVN $15 $1.48M −6.0% +21.2% −14.7% +80.2% −25.8%
Oct 25, 2022 BHVN $11 $8.96M +10.0% +32.8% −6.9% +91.9% −21.1%
Oct 5, 2022 BHVN $9 $647K +28.0% +12.5% +5.9% +97.1% −7.2%
Oct 5, 2022 BHVN $10 $341.8K +28.0% +12.5% +5.9% +97.1% −7.2%
Oct 5, 2022 BHVN $11 $875.8K +28.0% +12.5% +5.9% +97.1% −7.2%
Oct 5, 2022 BHVN $12 $642.6K +28.0% +12.5% +5.9% +97.1% −7.2%
Oct 5, 2022 BHVN $9 $644.1K +28.0% +12.5% +5.9% +97.1% −7.2%
Oct 5, 2022 BHVN $10 $341K +28.0% +12.5% +5.9% +97.1% −7.2%
Oct 5, 2022 BHVN $11 $871.9K +28.0% +12.5% +5.9% +97.1% −7.2%
Oct 5, 2022 BHVN $12 $619.2K +28.0% +12.5% +5.9% +97.1% −7.2%
Oct 5, 2022 BHVN $12 $25.9K +28.0% +12.5% +5.9% +97.1% −7.2%
Jun 26, 2019 BHVN $40 $201.1K +0.0% +0.0% +0.0% +0.0% +59.3%
How this is calculated. We score only open-market purchases (SEC code P) — the buys that carry real signal. Each trade's return is measured from the adjusted closing price on the purchase date to the latest close, accounting for stock splits and dividends. The 1M/3M/6M/12M columns show the same trade's return after each fixed holding period; a dash means that horizon hasn't elapsed yet or isn't priceable. Sales are excluded because insiders sell for many routine reasons. With only 22 scored trades, treat this as a small sample, not a verdict.
Open-market buys
$39.69M
22 trades
Open-market sells
$11.17M
22 trades
Net flow
+$28.52M
Net buying
Total filings
117
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
BHVN
Biohaven Ltd.
Option exercise Coric Vlad · Director, Chief Executive Officer · Option exercise · Jan 5, 2026
+$0
14,250 sh
BHVN
Biohaven Ltd.
Tax withholding Coric Vlad · Director, Chief Executive Officer · Tax withholding · Jan 5, 2026
−$73.8K
7,430 sh @ $10
BHVN
Biohaven Ltd.
Buy Coric Vlad · Director, Chief Executive Officer · Open-market purchase · Nov 13, 2025
+$2.5M
333,333 sh @ $8
BHVN
Biohaven Ltd.
Buy Coric Vlad · Director, Chief Executive Officer · Open-market purchase · Nov 13, 2025
+$2.5M
333,333 sh @ $8
BHVN
Biohaven Ltd.
Option exercise Coric Vlad · Director, Chief Executive Officer · Option exercise · Jan 5, 2025
+$0
14,250 sh
BHVN
Biohaven Ltd.
Tax withholding Coric Vlad · Director, Chief Executive Officer · Tax withholding · Jan 5, 2025
−$262.9K
6,805 sh @ $39
BHVN
Biohaven Ltd.
Buy Coric Vlad · Director, Chief Executive Officer · Open-market purchase · Oct 2, 2024
+$1,000K
21,052 sh @ $48
BHVN
Biohaven Ltd.
Buy Coric Vlad · Director, Chief Executive Officer · Open-market purchase · Apr 22, 2024
+$5M
121,951 sh @ $41
BHVN
Biohaven Ltd.
Grant/award Coric Vlad · Director, Chief Executive Officer · Grant/award · Apr 5, 2024
+$0
232 sh
BHVN
Biohaven Ltd.
Grant/award Coric Vlad · Director, Chief Executive Officer · Grant/award · Apr 5, 2024
+$0
231 sh
BHVN
Biohaven Ltd.
Grant/award Coric Vlad · Director, Chief Executive Officer · Grant/award · Apr 5, 2024
+$0
231 sh
BHVN
Biohaven Ltd.
Grant/award Coric Vlad · Director, Chief Executive Officer · Grant/award · Mar 8, 2024
+$0
2,162 sh
BHVN
Biohaven Ltd.
Grant/award Coric Vlad · Director, Chief Executive Officer · Grant/award · Mar 8, 2024
+$0
2,155 sh
BHVN
Biohaven Ltd.
Grant/award Coric Vlad · Director, Chief Executive Officer · Grant/award · Mar 8, 2024
+$0
2,155 sh
BHVN
Biohaven Ltd.
Grant/award Coric Vlad · Director, Chief Executive Officer · Grant/award · Jan 8, 2024
+$0
5,400 sh
BHVN
Biohaven Ltd.
Grant/award Coric Vlad · Director, Chief Executive Officer · Grant/award · Jan 8, 2024
+$0
5,384 sh
BHVN
Biohaven Ltd.
Grant/award Coric Vlad · Director, Chief Executive Officer · Grant/award · Jan 8, 2024
+$0
5,384 sh
BHVN
Biohaven Ltd.
Buy Coric Vlad · Director, Chief Executive Officer · Open-market purchase · Oct 5, 2023
+$7.5M
340,908 sh @ $22
BHVN
Biohaven Ltd.
Buy Coric Vlad · Director, Chief Executive Officer · Open-market purchase · Oct 5, 2023
+$2.5M
113,637 sh @ $22
BHVN
Biohaven Ltd.
Buy Coric Vlad · Director, Chief Executive Officer · Open-market purchase · Oct 31, 2022
+$412K
25,800 sh @ $16
BHVN
Biohaven Ltd.
Buy Coric Vlad · Director, Chief Executive Officer · Open-market purchase · Oct 28, 2022
+$623.4K
41,930 sh @ $15
BHVN
Biohaven Ltd.
Buy Coric Vlad · Director, Chief Executive Officer · Open-market purchase · Oct 28, 2022
+$1.48M
100,000 sh @ $15
BHVN
Biohaven Ltd.
Buy Coric Vlad · Director, Chief Executive Officer · Open-market purchase · Oct 25, 2022
+$8.96M
853,380 sh @ $11
BHVN
Biohaven Ltd.
Buy Coric Vlad · Director, Chief Executive Officer · Open-market purchase · Oct 5, 2022
+$647K
73,331 sh @ $9
BHVN
Biohaven Ltd.
Buy Coric Vlad · Director, Chief Executive Officer · Open-market purchase · Oct 5, 2022
+$341.8K
34,515 sh @ $10
BHVN
Biohaven Ltd.
Buy Coric Vlad · Director, Chief Executive Officer · Open-market purchase · Oct 5, 2022
+$875.8K
80,907 sh @ $11
BHVN
Biohaven Ltd.
Buy Coric Vlad · Director, Chief Executive Officer · Open-market purchase · Oct 5, 2022
+$642.6K
54,329 sh @ $12
BHVN
Biohaven Ltd.
Buy Coric Vlad · Director, Chief Executive Officer · Open-market purchase · Oct 5, 2022
+$644.1K
73,005 sh @ $9
BHVN
Biohaven Ltd.
Buy Coric Vlad · Director, Chief Executive Officer · Open-market purchase · Oct 5, 2022
+$341K
34,459 sh @ $10
BHVN
Biohaven Ltd.
Buy Coric Vlad · Director, Chief Executive Officer · Open-market purchase · Oct 5, 2022
+$871.9K
80,606 sh @ $11
BHVN
Biohaven Ltd.
Buy Coric Vlad · Director, Chief Executive Officer · Open-market purchase · Oct 5, 2022
+$619.2K
52,523 sh @ $12
BHVN
Biohaven Ltd.
Buy Coric Vlad · Director, Chief Executive Officer · Open-market purchase · Oct 5, 2022
+$25.9K
2,100 sh @ $12
BHVN
Biohaven Ltd.
Option exercise Coric Vlad · Director, Chief Executive Officer · Option exercise · Oct 3, 2022
+$2.5K
387 sh @ $6
BHVN
Biohaven Ltd.
Option exercise Coric Vlad · Director, Chief Executive Officer · Option exercise · Oct 3, 2022
+$220.5K
34,612 sh @ $6
BHVN
Biohaven Ltd.
Option exercise Coric Vlad · Director, Chief Executive Officer · Option exercise · Oct 3, 2022
+$5K
1,199 sh @ $4
BHVN
Biohaven Ltd.
Option exercise Coric Vlad · Director, Chief Executive Officer · Option exercise · Oct 3, 2022
+$201.5K
48,801 sh @ $4
BHVN
Biohaven Ltd.
Option exercise Coric Vlad · Director, Chief Executive Officer · Option exercise · Oct 3, 2022
+$124.3K
43,750 sh @ $3
BHVN
Biohaven Ltd.
Option exercise Coric Vlad · Director, Chief Executive Officer · Option exercise · Oct 3, 2022
+$158.5K
98,458 sh @ $2
BHVN
Biohaven Ltd.
Option exercise Coric Vlad · Director, Chief Executive Officer · Option exercise · Oct 3, 2022
+$2.5K
1,542 sh @ $2
BHVN
Biohaven Ltd.
Option exercise Coric Vlad · Director, Chief Executive Officer · Option exercise · Oct 3, 2022
+$9.9K
9,620 sh @ $1
BHVN
Biohaven Ltd.
Option exercise Coric Vlad · Director, Chief Executive Officer · Option exercise · Oct 3, 2022
+$93.1K
90,380 sh @ $1
BHVN
Biohaven Ltd.
Option exercise Coric Vlad · Director, Chief Executive Officer · Option exercise · Oct 3, 2022
+$10.8K
20,000 sh @ $1
BHVN
Biohaven Ltd.
Option exercise Coric Vlad · Director, Chief Executive Officer · Option exercise · Oct 3, 2022
+$11.5K
25,000 sh @ $0
BHVN
Biohaven Ltd.
Option exercise Coric Vlad · Director, Chief Executive Officer · Option exercise · Oct 3, 2022
+$14K
50,000 sh @ $0
BHVN
Biohaven Ltd.
Option exercise Coric Vlad · Director, Chief Executive Officer · Option exercise · Oct 3, 2022
+$10.5K
37,500 sh @ $0
BHVN
Biohaven Ltd.
Option exercise Coric Vlad · Director, Chief Executive Officer · Option exercise · Oct 3, 2022
+$5K
125,000 sh @ $0
BHVN
Biohaven Ltd.
Tax withholding Coric Vlad · Director, Chief Executive Officer · Tax withholding · Oct 3, 2022
−$869.6K
115,940 sh @ $8

Frequently asked questions

How is Coric Vlad's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Coric Vlad's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.